Evidence map›Paper›PMID 39368899›Full record

ArticleClinical oncology (Royal College of Radiologists (Great Britain))2024

"If You're Talking, I Think You're Muted": Follow-up Analysis of Weekly Peer Review Discussion and Plan Changes After Transitioning From Virtual to In-Person Format.

R T Hughes, J J Prasad, N B Razavian, J D Ververs, A C Snavely, C L Nightingale, K E Weaver, M D Chan, M K Farris

Abstract read
In one paragraph

Article in Clinical oncology (Royal College of Radiologists (Great Britain)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

R T HughesDepartment of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States. Electronic address: ryhughes@wakehealth.edu.
J J PrasadDepartment of Psychology, Colorado State University College of Natural Sciences, Fort Collins, Colorado, United States.
N B RazavianDepartment of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
J D VerversDepartment of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
A C SnavelyDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
C L NightingaleDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
K E WeaverDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
M D ChanDepartment of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
M K FarrisDepartment of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Wake Forest Clinical and Translational Science AwardKL2TR001421 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MILLER, DAVID P · 2015 to 2023
$5.8M
NCATS NIH HHS KL2 TR001421NCATS NIH HHS UL1 TR001420
6 · The paper itself

Abstract

aimsDuring the COVID-19 public health emergency, we previously identified decreased rates of radiotherapy (RT) peer review (PR) discussion and plan changes in virtual versus in-person PR conferences. To expand on these findings, we continued to prospectively collect data on all PR conferences from 2021 to 2023 and performed a follow-up analysis before and after the transition back to in-person PR. MATERIALS AND

methodsA prospectively maintained database of weekly PR cases was queried for consecutive cases reviewed before and after the transition from virtual to in-person conferences. Rates of PR discussion and change recommendations were summarized and compared between the virtual and in-person groups. A survey was developed and administered to assess participants' perceived levels of engagement, opinions on optimal PR format, and preferences for future meetings before and 3 months after the transition back to in-person PR.

resultsIn total, 2,103 RT plans were reviewed: 1,590 virtually and 513 after the transition back to in-person. There was no difference in faculty attendance between groups. The proportion of cases with PR discussion increased from virtual (9.8%) to in-person (25.5%) format (p < 0.001). In the virtual group, 8.1% of cases had 1 topic and 1.7% had 2+ topics discussed. This increased to 15.8% and 9.7% during in-person PR, respectively (p < 0.001). The rate of change recommendation also increased from 1.5% (virtual) to 3.3% (in-person, p = 0.016). Among cases with at least 1 topic discussed, there was no difference in changes. Survey-reported distraction significantly decreased from virtual to in-person PR (p < 0.001).

conclusionUpon returning to in-person PR conferences, peer discussion and plan change recommendations significantly increased and returned to pre-pandemic levels, and participants' perceived levels of distraction were reduced. In an increasingly virtual world, additional efforts to develop best practices that maximize PR discussion and minimize distraction outside virtual conferences are warranted.

Indexed as

COVID-19Follow-Up StudiesHumansProspective StudiesSARS-CoV-2Chart roundspeer reviewquality assuranceradiation oncologytelehealthvirtual medicine

Identifiers

PMID39368899
PMCPMC12004210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.